Maureen Clare Mommaerts, PT in Green Bay, WI - Medicare Physical Therapy Provider

Maureen Clare Mommaerts, PT is a medicare enrolled "Physical Therapist" provider in Green Bay, Wisconsin. She graduated from medical school in 2002 and has 22 years of diverse experience with area of expertise as Physical Therapy. She is a member of the group practice St Vincent Hospital-hospital Sisters-third Order Of St Francis and her current practice location is 1726 Shawano Ave, Green Bay, Wisconsin. You can reach out to her office (for appointments etc.) via phone at (920) 498-4267.

Maureen Clare Mommaerts is licensed to practice in Wisconsin (license number 9905-24) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1033547476.

Contact Information

	Maureen Clare Mommaerts, PT
	1726 Shawano Ave, Green Bay, WI 54303-3216
	(920) 498-4267
	(920) 498-4271

Healthcare Provider's Profile

Full Name	Maureen Clare Mommaerts
Gender	Female
Speciality	Physical Therapy
Experience	22 Years
Location	1726 Shawano Ave, Green Bay, Wisconsin
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Maureen Clare Mommaerts graduated from medical school in 2002

NPI Data:

NPI Number: 1033547476
Provider Enumeration Date: 10/22/2013
Last Update Date: 10/15/2020

Medicare PECOS Information:

PECOS PAC ID: 3577790658
Enrollment ID: I20131217000487

Medical Identifiers

Medical identifiers for Maureen Clare Mommaerts such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033547476	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	9905-24 (Wisconsin)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
St Vincent Hospital-hospital Sisters-third Order Of St Francis	5799694675	562

News Archive

Amgen's AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Amgen (NASDAQ: AMGN) today announced that a second placebo-controlled Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints.

Janssen, BeiGene enter in-licensing agreement for two clinical-stage oncology compounds

BeiGene, Ltd., today announced that it has entered into exclusive in-licensing and co-development agreements with Janssen Pharmaceutica NV and its affiliates for two clinical-stage oncology compounds.

Scientists discover, count and determine new mitochondrial proteome in baker's yeast

Mitochondria, best known for their role as powerhouses of eukaryotic cells, fulfill numerous vital functions. Knowledge about the precise protein composition as well as the functions of individual proteins is essential to understand fundamental processes of cell biology and diseases that are caused by cellular defects.

Drug trial participants should be better informed about benefits and side-effects of placebos

Research carried out at the University of Southampton has concluded that participants in drug trials should be better informed about the potential significant benefits and possible side-effects of placebos.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Maureen Clare Mommaerts allows following entities to bill medicare on her behalf.

Provider Name	St. Nicholas Hospital-sisters Of The Third Order Of St Francis
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1275799413 PECOS PAC ID: 8325931652 Enrollment ID: O20040202001172

News Archive

Amgen's AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Janssen, BeiGene enter in-licensing agreement for two clinical-stage oncology compounds

Scientists discover, count and determine new mitochondrial proteome in baker's yeast

Drug trial participants should be better informed about benefits and side-effects of placebos

Provider Name	St Vincent Hospital-hospital Sisters-third Order Of St Francis
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1285613638 PECOS PAC ID: 5799694675 Enrollment ID: O20080620000423

Amgen's AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Janssen, BeiGene enter in-licensing agreement for two clinical-stage oncology compounds

Scientists discover, count and determine new mitochondrial proteome in baker's yeast

Drug trial participants should be better informed about benefits and side-effects of placebos

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Maureen Clare Mommaerts is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Maureen Clare Mommaerts, PT Po Box 19070, Green Bay, WI 54307-9070 Ph: (920) 496-4700	Maureen Clare Mommaerts, PT 1726 Shawano Ave, Green Bay, WI 54303-3216 Ph: (920) 498-4267

News Archive

Amgen's AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Janssen, BeiGene enter in-licensing agreement for two clinical-stage oncology compounds

Scientists discover, count and determine new mitochondrial proteome in baker's yeast

Drug trial participants should be better informed about benefits and side-effects of placebos

Physical Therapist in Green Bay, WI

Anne Marie Hein, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3101 S Packerland Dr, Green Bay, WI 54313 Phone: 920-592-3845
Ellen Linskens, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2845 Greenbrier Rd, Green Bay, WI 54311 Phone: 920-288-8000
Alexander Lee Peterson, D-PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3263 Eaton Rd, Green Bay, WI 54311 Phone: 920-433-6700 Fax: 920-433-6719
Mr. Thomas J Krahn, DPT, LAT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2502 S. Ashland Ave., Green Bay, WI 54304 Phone: 920-496-4750
Tony James Busse, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1920 Libal St, Green Bay, WI 54301 Phone: 920-433-0111 Fax: 920-433-8765
Jill Ball, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1760 Shawano Ave, Green Bay, WI 54303 Phone: 605-830-8227
Samuel Adam Krier, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1630 Commanche Ave, Green Bay, WI 54313 Phone: 920-430-4700

Maureen Clare Mommaerts, PT - Medicare Physical Therapist in Green Bay, WI

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Amgen's AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Janssen, BeiGene enter in-licensing agreement for two clinical-stage oncology compounds

Scientists discover, count and determine new mitochondrial proteome in baker's yeast

Drug trial participants should be better informed about benefits and side-effects of placebos

Medicare Reassignments

Amgen's AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Janssen, BeiGene enter in-licensing agreement for two clinical-stage oncology compounds

Scientists discover, count and determine new mitochondrial proteome in baker's yeast

Drug trial participants should be better informed about benefits and side-effects of placebos

Amgen's AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Janssen, BeiGene enter in-licensing agreement for two clinical-stage oncology compounds

Scientists discover, count and determine new mitochondrial proteome in baker's yeast

Drug trial participants should be better informed about benefits and side-effects of placebos

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Amgen's AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Janssen, BeiGene enter in-licensing agreement for two clinical-stage oncology compounds

Scientists discover, count and determine new mitochondrial proteome in baker's yeast

Drug trial participants should be better informed about benefits and side-effects of placebos

Physical Therapist in Green Bay, WI